Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
8,416,137
-
Share change
-
+114,729
-
Total reported value
-
$1,591,951,701
-
Price per share
-
$189.07
-
Number of holders
-
190
-
Value change
-
+$22,075,913
-
Number of buys
-
87
-
Number of sells
-
74
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2025
As of 31 Dec 2025,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,416,137 shares.
The largest 10 holders included
VANGUARD GROUP INC, Chicago Capital, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Stephens Investment Management Group LLC, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, CONGRESS ASSET MANAGEMENT CO, GOLDMAN SACHS GROUP INC, DEUTSCHE BANK AG\, and VILLERE ST DENIS J & CO LLC.
This page lists
190
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.